Oxion Biologics
Phase 1Oxion Biologics is a biotechnology company that develops novel therapeutics for the treatment of autoimmune diseases.
Founded
2018
Focus
Biologics
About
Oxion Biologics is a biotechnology company that develops novel therapeutics for the treatment of autoimmune diseases.
Funding History
2Total raised: $3M
Grant$500KVinnovaMar 15, 2022
Seed$2.5MAlmi InvestJun 15, 2021
Company Info
TypePrivate
Founded2018
LocationStockholm, Sweden
StagePhase 1
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile